Coronavirus: Global Kovid-19 death toll reaches one million

A man dressed in a labor suit burned a man's coffin on September 23, 2020 in Jakarta, IndonesiaImage copyright

image Caption

Funerals for victims, such as in Indonesia, have to be done using tight security

With Kovid-19 taking the death toll worldwide to one million, researchers say the number of new infections is still increasing in many areas.

The rally by Johns Hopkins University shows that deaths in the US, Brazil and India together account for almost half of all deaths.

Experts caution that the correct figure is probably too high.

UN Secretary-General Antonio Guterres called it a “mind-numbing” figure and “an annoying milestone”.

“Yet we must never lose the life of every person,” he said in a video message.

“They were fathers and mothers, wives and husbands, brothers and sisters, friends and co-workers. The pain has increased manifold due to the prevalence of the disease.”

The development has come to light nearly 10 months after reports of coronavirus from Wuhan, China.

The epidemic has spread to 188 countries with more than 32 million confirmed cases. Lockdowns and other measures to prevent the virus from spreading have thrown many economies into recession.

Meanwhile, efforts are underway to develop an effective vaccine – although the World Health Organization (WHO) has warned that the death toll could be as high as two million before it becomes widely available.

America had the world’s highest number of deaths with 205,000 factories, followed by 141,700 in Brazil and 95,500 in India.

Where is Kovid-19 spreading fastest?

The US has reported more than seven million cases – more than a fifth of the world’s total. After a second wave of cases in July, the number decreased in August but is now increasing again.

Coronovirus is spreading rapidly in India, with a record of about 90,000 cases in the country a day before in September.

  • Where are the global coronavirus hotspots?

Confirmed infection in India has reached six million – the second highest after the US. However, given the size of its population, India has seen relatively low mortality.

Media playback is unsupported on your device

Media captionSome suspected coronavirus patients in India turn away from hospitals

Brazil has the highest number of deaths in Latin America and is the third highest in the world with more than 4.7 million cases reported.

In the region, newly confirmed infections are also increasing rapidly in Argentina, with more than 700,000 cases now.

  • Age and climate are seen behind fewer cases of Africa.

The latest height suggests that about 1.5 million people in Africa have been confirmed as contracting coronavirus, with approximately 35,000 deaths.

The small, less densely populated and hot, humid climate is being cited as the leading cause, as the continent has a high number of cases. The WHO has also praised the “decisive” action by African countries.

Experts say how cases and deaths differ among countries – and sporadic rates of testing in some regions – are higher than the true number of coronovirus cases and deaths reported.

How is the hunt for vaccine progression?

There are approximately 240 potential vaccines in early development globally, with 40 in clinical trials and nine in the final stages of testing. The development of a vaccine usually takes years, but due to the global emergency, scientists are working at a breakneck pace.

Being developed by the University of Oxford – already at an advanced stage of testing – it has been shown that it can trigger an immune response and an agreement with AstraZeneca to supply 100 million doses in the UK alone Has been signed.

  • When will we have the vaccine?
  • Who will get the vaccine and how?

In China, a potential vaccine has been shown to produce protective antibodies and is being made available to the Chinese military. However, concerns have been expressed about the speed with which the vaccine is being produced.

Media playback is unsupported on your device

Media captionCoronavirus Vaccine: How Close Are We and Who Will Get It?

Meanwhile in Russia, scientists say preliminary tests on a vaccine called Sputnik-V show signs of an immune response.

In a report earlier this month, he said that every participant in the tests developed antibodies to fight the virus and had no serious side effects.

Russia licensed the vaccine for local use in August – the first country to do so. Again, there was concern over the speed of the process and some experts said that initial tests were too small to prove effectiveness and safety.

In the US, President Donald Trump has said that Americans should be able to use the vaccine in early October, although the Centers for Disease Control and Prevention says a vaccine is unlikely to become widely available before mid-2021 is.

The WHO has stated that it does not expect to see widespread vaccination against Kovid-19 until mid-2021.

Media playback is unsupported on your device

Media captionHealth workers in Venezuela say they have been forced to work under unsafe conditions

Leave a Reply

Your email address will not be published.